Leaders in Poppy Production
The Tasmanian Poppy Industry was pioneered by Glaxo Australia in the early 1960s. It is one of the success stories of Australian agriculture and manufacturing.
Founded with the objective of providing a reliable and secure source of opiate alkaloids, GlaxoSmithKline has grown to become one of the world's major suppliers, with an international reputation for security, reliability and quality.
This growth has been based on the innovative development and usage of technology in all aspects of the operation, and has resulted in GlaxoSmithKline being recognised as the most cost-effective international producer.
GlaxoSmithKline continues to pioneer advances in the industry, providing world markets with a reliable and secure source of alkaloids for analgesic medicines.
Over 90% of the thebaine, codeine and morphine produced is sold to export markets.
Tassie poppies – helping the world
GSK supplies 25% of the world's medicinal opiate needs from poppies grown by farmers in Tasmania.
Through significant developments and the application of innovative research and development, GSK continues to contract with and assist Tasmanian farmers to grow poppy crop, directly contributing to the word’s medicinal opiate needs. The opiates are extracted from the poppies at our factory in Port Fairy, Victoria and are used in a range of pharmacy and prescription medicines worldwide.
We are continually researching how to develop new varieties of poppy and improve growing techniques that will increase the poppy and alkaloid yields, and make the crop safer.